Cureety

Sou profissional de saúde

Profissional de saúde

Evidência clínica, detalhes de integração e especificações de produto para equipas de oncologia.

Sou doente ou cuidador

Doente ou cuidador

Informações sobre a Cureety como sua companheira diária durante o percurso do tratamento.

Feasability

Patients enrolled in the program

Participating center(s) across the study

Effectiveness of electronic patient reporting outcomes, by a digital telemonitoring platform, for prostate cancer care: the Protecty study

A prospective, observational, monocentric study to measure compliance with the use of Cureety in patients with prostate cancer.

Evolution of patients' compliance after 6 months, based on their health quality

High remote monitoring compliance of 72% during the first month, 59% at 8 months.

Patients divided in 2 groups based on the 1st month of monitoring: 'Healthy' (87%) and 'Poor Health' (13%).

29% increase of progression-free survival at 6 months in the 'Healthy' group (p = 0.17).

14% increase of overall survival at 6 months in the 'Healthy' group (p = 0.15).

Helissey et al., 2023, Front. Digit. Health